296 related articles for article (PubMed ID: 30391771)
1. Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases.
Della Puppa A; Munari M; Gardiman MP; Volpin F
World Neurosurg; 2019 Feb; 122():e856-e863. PubMed ID: 30391771
[TBL] [Abstract][Full Text] [Related]
2. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.
Yano H; Nakayama N; Ohe N; Miwa K; Shinoda J; Iwama T
J Neurooncol; 2017 Jun; 133(2):389-397. PubMed ID: 28432590
[TBL] [Abstract][Full Text] [Related]
3. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
4. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
5. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
[TBL] [Abstract][Full Text] [Related]
7. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA-Induced Fluorescence in High-Grade Gliomas.
Vogelbaum MA; Kroll D; Etame A; Tran N; Liu J; Ford A; Sparr E; Kim Y; Forsyth P; Sahebjam S; Mokhtari S; Peguero E; Macaulay R
World Neurosurg; 2021 May; 149():e498-e503. PubMed ID: 33561551
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
11. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided surgery for high-grade gliomas.
Lakomkin N; Hadjipanayis CG
J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
[TBL] [Abstract][Full Text] [Related]
13. The use of the YELLOW 560 nm surgical microscope filter for sodium fluorescein-guided resection of brain tumors: Our preliminary results in a series of 28 patients.
Hamamcıoğlu MK; Akçakaya MO; Göker B; Kasımcan MÖ; Kırış T
Clin Neurol Neurosurg; 2016 Apr; 143():39-45. PubMed ID: 26895208
[TBL] [Abstract][Full Text] [Related]
14. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma.
Fan C; Jiang Y; Liu R; Wu G; Wu G; Xu K; Miao Z
Clin Neurol Neurosurg; 2018 Dec; 175():57-60. PubMed ID: 30384117
[TBL] [Abstract][Full Text] [Related]
16. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
17. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
18. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
19. Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
Cordova JS; Shu HK; Liang Z; Gurbani SS; Cooper LA; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG; Hadjipanayis CG; Shim H
Neuro Oncol; 2016 Aug; 18(8):1180-9. PubMed ID: 26984746
[TBL] [Abstract][Full Text] [Related]
20. Complementary Molecular and Elemental Mass-Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery.
Kröger S; Niehoff AC; Jeibmann A; Sperling M; Paulus W; Stummer W; Karst U
Anal Chem; 2018 Oct; 90(20):12253-12260. PubMed ID: 30215510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
